B+
Bull case
25%
Probability
Target price
$2.05
Analysis reference price unavailable
Analysis 2026-10-29 · RankAlpha Sentiment Codex
RLX
RLXBNYSE / Food Beverage & Tobacco
Last Price
Quote time unavailable
AI scenario view
RankAlpha Sentiment CodexMost likely
B
Base case
50%
Probability
Target price
$1.65
Analysis reference price unavailable
Analysis 2026-10-29 · RankAlpha Sentiment Codex
B-
Bear case
25%
Probability
Target price
$1.15
Analysis reference price unavailable
Analysis 2026-10-29 · RankAlpha Sentiment Codex
The current persistence contract does not provide an exact AI reference price. RankAlpha therefore does not calculate scenario return from the live quote. How scenarios are presented
AI sentiment snapshot
Latest data as of 2026-10-29
Recent news sentiment (30D)
0.0
Mixed
Company
-
Unavailable
Macro
-
Unavailable
Pulse
-
Unavailable
Weekly research (10D)
-
Unavailable
Sentiment proxy
+64.7
Score
AI commentary
The latest release listed on RLX's investor-relations news page is the August 14 Q2 report. The supplied October article is third-party valuation commentary, not a company earnings release. No attributable recent price reaction, analyst revisions, consensus surprise, or sufficient social, options and short-interest measurements were verified; zeros above mean unavailable, not neutral. The deterministic evidence-quality score of 0.08 and uncertainty score of 0.906 support monitoring rather than a strong directional thesis.
RankAlpha Sentiment Codex - 2026-10-29
Open full AI memoEvidence flagged
No evidence quality warning is currently attached to this memo.
Impact
standard
Confidence
-
AI events
2026-12-31eventFirst reported contribution from Western European distributorHigh impact
RLX said it acquired 51% and board control of a Western European distributor in July and would begin consolidating its results in Q3 2026. The next results can test the contribution and integration costs; RLX did not quantify an expected benefit. The date is a monitoring horizon, not an announced reporting date. [#IR-2026-08-14] RLX Q2 release
2026-12-31catalystCash-conversion and margin testMedium impact
Q2 revenue rose 14.8% year over year and gross margin reached 35.4%, but operating activities used RMB63.2 million of cash. Subsequent results need to show whether improved product mix and supply-chain efficiency translate into cash generation. The date is an assessment horizon. [#IR-2026-08-14] RLX Q2 release
2027-06-30catalystProfitability of international product expansionHigh impact
International business represented 68.5% of Q2 revenue, while management said it was scaling newly launched oral nicotine pouches alongside e-vapor. Durable upside depends on evidence of profitable retail execution, not expansion alone. The date is an assessment horizon, not a company milestone. [#IR-2026-08-14] RLX Q2 release
Recommendation
N/A
No formal recommendation provided.
As of 2026-10-29 • Updated nightlySource: Internal modelMethodology